175 related articles for article (PubMed ID: 25892103)
21. Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II).
Jayatunga MK; Thompson S; McKee TC; Chan MC; Reece KM; Hardy AP; Sekirnik R; Seden PT; Cook KM; McMahon JB; Figg WD; Schofield CJ; Hamilton AD
Eur J Med Chem; 2015 Apr; 94():509-16. PubMed ID: 25023609
[TBL] [Abstract][Full Text] [Related]
22. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
[TBL] [Abstract][Full Text] [Related]
23. Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma.
Lee SH; Kang JH; Ha JS; Lee JS; Oh SJ; Choi HJ; Song J; Kim SY
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708896
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
25. NF-κB suppresses HIF-1α response by competing for P300 binding.
Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells.
Yoshida T; Hashimura M; Mastumoto T; Tazo Y; Inoue H; Kuwata T; Saegusa M
Lab Invest; 2013 Nov; 93(11):1184-93. PubMed ID: 24042437
[TBL] [Abstract][Full Text] [Related]
27. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
[TBL] [Abstract][Full Text] [Related]
28. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
[TBL] [Abstract][Full Text] [Related]
29. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
30. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
Li J; Xi W; Li X; Sun H; Li Y
Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitive termination of the hypoxic response by a disordered protein switch.
Berlow RB; Dyson HJ; Wright PE
Nature; 2017 Mar; 543(7645):447-451. PubMed ID: 28273070
[TBL] [Abstract][Full Text] [Related]
32. The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.
Moin SM; Chandra V; Arya R; Jameel S
Cell Microbiol; 2009 Sep; 11(9):1409-21. PubMed ID: 19489936
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α.
Shimizu T; Takahashi N; Huber VJ; Asawa Y; Ueda H; Yoshimori A; Muramatsu Y; Seimiya H; Kouji H; Nakamura H; Oguri H
Bioorg Med Chem; 2021 Jan; 30():115949. PubMed ID: 33360196
[TBL] [Abstract][Full Text] [Related]
35. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization.
Usui-Ouchi A; Aguilar E; Murinello S; Prins M; Gantner ML; Wright PE; Berlow RB; Friedlander M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28297-28306. PubMed ID: 33106407
[TBL] [Abstract][Full Text] [Related]
36. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
Schmid T; Zhou J; Köhl R; Brüne B
Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
[TBL] [Abstract][Full Text] [Related]
37. NDRG3 lowers the metastatic potential in prostate cancer as a feedback controller of hypoxia-inducible factors.
Lee GY; Shin SH; Shin HW; Chun YS; Park JW
Exp Mol Med; 2018 May; 50(5):1-13. PubMed ID: 29760417
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein.
Ruas JL; Poellinger L; Pereira T
J Biol Chem; 2002 Oct; 277(41):38723-30. PubMed ID: 12133832
[TBL] [Abstract][Full Text] [Related]
39. Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models.
Harris EM; Strope JD; Beedie SL; Huang PA; Goey AKL; Cook KM; Schofield CJ; Chau CH; Cadelis MM; Copp BR; Gustafson KR; Figg WD
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029505
[TBL] [Abstract][Full Text] [Related]
40. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW
Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]